|
|
|
 |
Search published articles |
 |
|
Showing 6 results for Subject: Gynecology
Mandana Mansourghanaie, Ehsan Kazemnejad , Seyed Alaadin Asgari, Neda Azadian ,
Volume 18, Issue 3 (10-2018)
Abstract
Background & objectives: Evaluation of liver and renal function before and after administration of methotrexate (MTX) is recommended in the treatment of molar pregnancy, but the necessity of performing these tests during treatment of ectopic pregnancy (EP) is not clear. The aim of this study was to evaluate the changes of creatinine and AST levels before and after treatment with double (DD) and multiple (MD) doses of MTX in patients with Ep.
Methods: This retrospective cross-sectional study performed on 152 patients with an EP during 2007-2013 in Al-Zahra hospital (Rasht). Seventy six patients received DD and 76 cases were treated with MD of MTX. The success rate, side effects of MTX and changes in creatinine and AST levels were compared between the two groups.
Results: The mean changes in creatinine level was 0.06±0.08 and 0.16±0.13 in DD and MD groups, respectively and the difference between the two groups was statistically significant (p=0.002). The mean changes in AST level was 5.06±2.47 and 9.63±5.5 in DD and MD groups, respectively which was statistically significant (p=0.002). The success rates were 65.8% and 86.8% in DD and MD groups, respectively with statistically significant difference (p=0.002). The side effects rates were 13.2% and 32.9% in DD and MD groups, respectively with statistically significant difference (p=0.004).
Conclusion: It seems that administration of MD of MTX in EP patients leads to an increase in success rate of treatment but also it causes considerable increase in creatinine and AST levels.
Ms Shadi Sabetghadam, Afsaneh Keramat, Mina Malary, Sedighe Rezaie Chamani,
Volume 19, Issue 3 (10-2019)
Abstract
Introduction & objectives: Vaginismus is an uncontrolled contraction of the outer third muscle of the vagina that prevents intercourse. Based on the DSM-V-TR system, this disorder is associated with dyspareunia and "Genito-pelvic pain/penetration disorder". The purpose of this overview was to summarize population-based studies that reported the prevalence of vaginismus in the general population and to discover the discrepancies between studies.
Methods: This systematic review study was conducted on published articles on the prevalence of vaginismus in the world and in English. In selecting the articles, the keywords including Vaginismus, Prevalence, Incidence, Sexual Dysfunction, Genito-Pelvic Pain, Penetration Disorder with all possible combinations were systematically searched in the google scholar, science direct, PubMed, Cochrane databases. No search time limit was set to retrieve all relevant articles published by September 21, 2018.
Results: Of the 10 studies, 4 articles reported prevalence of vaginismus in the general population. In selected studies, the incidence of vaginismus in the general population of women was reported 0.4% to 8%.
Conclusion: Different prevalence rates have been reported in different studies for vaginismus. In this review study, it was not possible to Meta-analyze and determines the overall prevalence due to the heterogeneity of the prevalence reports and different study methods.
Reza Javanshir, Ramin Salimnejad, Mohammad Ghasem Golmohammadi, Hossein Kalarestaghy,
Volume 23, Issue 2 (7-2023)
Abstract
Premature Ovarian Insufficiency (POI) refers to the loss of ovarian function before the age of 40. This condition can be attributed to various factors including X chromosome abnormalities, autoimmune disorders, and chemotherapy drugs. Hormone therapy is a commonly used treatment for POI, but due to side effects and low fertility rates, alternative treatment options are needed. In recent years, stem cell transplantation has emerged as a promising treatment approach, offering hope for improving and restoring ovarian function. Stem cells possess the unique ability of self-renewal and regeneration, making them potentially effective in addressing ovarian failure and subsequent infertility. Different types of stem cells have been investigated for the treatment of POI, including mesenchymal stem cells (MSCs), stem cells from extraembryonic tissues, induced pluripotent stem cells (iPSCs), and ovarian stem cells. This article aims to provide an overview of the causes and treatment options for Premature Ovarian Insufficiency, with a particular focus on stem cell therapy as suggested by previous studies.
Corresponding Author: Hossein Kalarestaghy, Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Email: h.kalarestaghy111@gmail.com
google scholar
pubmed
Reza Javanshir, Hossein Kalarestaghy, Ramin Salimnejad,
Volume 24, Issue 2 (7-2024)
Abstract
Background: Premature ovarian insufficiency (POI) is the cessation of ovarian function in women under 40. One of the mechanisms involved in the induction of POI is oxidative stress. This study aims to investigate the effect of caffeic acid on the morphometrical changes of ovarian follicles of POI model mice.
Methods: Thirty-two female mice were randomly divided into 4 groups (n=8): 1) Control group (cont), 2) Caffeic acid group (CAF), 3) Premature ovarian insufficiency group (POI), and 4) Premature ovarian insufficiency + Caffeic acid group (POI+CAF). POI was induced through daily subcutaneous injections of D-galactose (200 mg/kg) for 6 weeks. Caffeic acid (60 mg/kg, intraperitoneal) was injected daily for 4 weeks from 15th day. One day after the last injection, the mice were anesthetized and the ovaries were removed. Then, the morphometric changes of ovarian follicles were examined using hematoxylin-eosin (H&E) staining.
Results: The results showed that D-Galactose-induced POI significantly decreases the diameter of primary, secondary, and antral follicles (P<0.05). Administration of caffeic acid in the POI+CAF group significantly prevented the reduction of follicle diameter (P<0.05).
Conclusion: The results showed that caffeic acid can prevent the reduction of the diameter of ovarian follicles in POI model mice.
Melika Izadpanah,
Volume 24, Issue 2 (7-2024)
Abstract
Endometriosis is a long-term health condition that is known as a significant factor in women's infertility issues nowadays. Since many factors contribute to the development of this disease and because diagnosis is difficult and typically happens late in the progression of the disease, early detection is especially crucial. Extracellular micro vesicles called exosomes have diverse biological molecules and can alter the behavior of recipient cells, influencing angiogenesis, fibrosis, and inflammation. Exosomes are significant in cell communication and could act as new biomarkers for early detection of endometriosis. Hence, exploring and comprehending the impact of exosomes on the development of endometriosis can create opportunities for studying potential diagnostic biomarkers and targeted therapeutic interventions to prevent the advancement of the condition. This article delves into new approaches to diagnose and treat endometrial disorders by highlighting the various functions of exosomes in endometriosis.
Samira Shahbazzadegan, Mohammad Ali Mohammadi, Iraj Feizi, Faredeh Mostafazadeh, Rana Beheshti,
Volume 24, Issue 4 (1-2025)
Abstract
Background: Fertility is one of the important challenges of women with breast cancer. The incidence of breast cancer among women aged 20 to 49 is gradually increasing, and at the same time, there is evidence that the age of first pregnancy is also increasing, and this requires attention to these issues. Therefore, the present study was conducted with the aim of determining the fertility desire in women with breast cancer in Ardabil in 2024.
Methods: This descriptive study was conducted on women with breast cancer in Ardabil city using a census method. After obtaining the code of ethics and receiving an introduction letter and informed consent from the participants, data were collected using a demographic information questionnaire and a specific fertility desire questionnaire for women with breast cancer. Data analysis was performed using SPSS software using descriptive and analytical statistics.
Results: Data from 180 breast cancer patients were analyzed. The mean fertility desire was 37.86 ± 11.86, which was significantly lower than the criterion value (45) (p<0.001). The mean score of the disease control dimension was 17.81, which was significantly higher than the criterion value (14). The scores of the pregnancy risk, social support, and happiness dimensions were significantly lower than the criterion value (p<0.001). There was a significant relationship between the number of children and the method of adjuvant therapy with fertility desire (p<0.01 and p<0.04, respectively).
Conclusion: Fertility desire in women with breast cancer was low. The reason for the low desire to be fertile was related to the low disease control, social support, and happiness in patients, while it was not related to the risk of the disease. There was a relationship between the desire to be fertile with the treatment method and the number of children and age. The desire to be fertile was higher in women who used chemotherapy alone than in women treated with both chemotherapy and radiotherapy. Also, the desire to be fertile was higher in women with fewer children than in women with more children, and also women with younger age had a higher desire to become pregnant. The study results showed that young women with breast cancer need more attention regarding disease control, social support, and happiness.
|
|
.png)
.png)
